Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. [electronic resource]
Producer: 20010823Description: 1735-40 p. digitalISSN:- 0012-1797
- Adolescent
- Adult
- Analysis of Variance
- Autoantibodies -- blood
- Child
- Child, Preschool
- Clinical Trials as Topic -- methods
- Diabetes Mellitus, Type 1 -- drug therapy
- Ethnicity
- Family
- Female
- Glutamate Decarboxylase -- immunology
- HLA-DQ Antigens -- genetics
- Humans
- Infant
- Insulin -- blood
- Insulin Antibodies -- blood
- Insulin Secretion
- Isoenzymes -- immunology
- Male
- Middle Aged
- Multicenter Studies as Topic -- methods
- Patient Selection
- Predictive Value of Tests
- Reproducibility of Results
- United States
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.